The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
COINBASE GLOBAL INC COM CL A 19260Q107   3,297,672 13,281 SH   DFND   13,281 0 0
DRAFTKINGS INC COM CL A 26142V105   11,971,109 321,804 SH   DFND   0 321,804 0
ENTRADA THERAPEUTICS, INC. COM 29384C108   13,162,479 761,277 SH   DFND   761,277 0 0
GROVE COLLABORATIVE HOLDINGS, INC. COM CL A 39957D201   528,732 380,383 SH   DFND   380,383 0 0
HILLEVAX, INC. COM 43157M102   1,710,998 826,569 SH   DFND   826,569 0 0
MONEYLION, INC. CL A 60938K304   53,578,295 622,931 SH   DFND   622,931 0 0
NEUEHEALTH INC. COM NEW 10920V404   3,897,333 525,247 SH   DFND   525,247 0 0
ONKURE THERAPEUTICS INC COM CL A 68277Q105   4,230,667 491,938 SH   DFND   491,938 0 0
PHATHOM PHARMACEUTICALS, INC. COM 71722W107   3,427,330 422,085 SH   DFND   422,085 0 0
RAMACO RES INC COM CL A 75134P600   38,855 3,787 SH   DFND   3,787 0 0
SENTINELONE INC CL A 8173OH109   784,237 35,326 SH   DFND   35,326 0 0
TENAYA THERAPEUTICS, INC. COM 87990A106   660,893 462,163 SH   DFND   462,163 0 0
UIPATH, INC. CL A 90364P105   16,351,758 1,286,527 SH   DFND   1,286,527 0 0
VACASA, INC. CL A NEW 91854V206   721,579 147,261 SH   DFND   147,261 0 0